TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that it has launched the first ANDA generic Triamterene 50 mg and 100 mg Capsules in collaboration with Agnitio Inc. Agnitio is supplying this limited competition item exclusively to TruPharma pursuant to a master agreement. Agnitio was the first company to receive FDA approval of a product determined to be bioequivalent and therapeutically equivalent to DYRENIUM® Capsules, 50 mg and 100 mg of Concordia Pharmaceuticals, Inc.